Lannett Company Inc
Change company Symbol lookup
Select an option...
LCI Lannett Company Inc
TESS TESSCO Technologies Inc
CLM Cornerstone Strategic Value Fund
HRC Hill-Rom Holdings Inc
QRTEB Qurate Retail Inc
GGN GAMCO Global Gold, Natural Resources & Income Trust
GGN GAMCO Global Gold, Natural Resources & Income Trust
GFY Western Asset Variable Rate Strategic Fund Inc
GE General Electric Co
GDXJ VanEck Vectors Junior Gold Miners ETF
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June 30, 2016, the Company's products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules. The Company has additional products under development, which are orally administered solid oral-dosage products (tablet/capsule) or oral solutions, nasal, topicals or parentarels, as well as other dosage forms.

Closing Price
$8.95
Day's Change
-0.85 (-8.67%)
Bid
--
Ask
--
B/A Size
--
Day's High
10.05
Day's Low
8.93
Volume
(Heavy Day)
Volume:
1,613,577

10-day average volume:
1,026,236
1,613,577

Upcoming Events

LCI's fiscal year ends in June
There are no upcoming events for LCI

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
November 6, 2019Q1 2020 Earnings Release$0.22$0.16 to $0.25$0.44
August 27, 2019Q4 2019 Earnings Release$0.37$0.19 to $0.22$0.64
May 6, 2019Q3 2019 Earnings Release$0.68$0.58 to $0.66$0.80
February 6, 2019Q2 2019 Earnings Release$0.86$0.66 to $0.68--

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.